Now showing items 1-4 of 4
Influence of drug class and healthcare setting on systemic antifungal expenditures in the United States, 2005–15
(American Society of Health-System Pharmacists, 2017-07)
Purpose Overall and specific class trends in systemic antifungal expenditures in various U.S. healthcare settings from 2005 through 2015 were evaluated. Methods Systemic antifungal expenditures from January 1, 2005, ...
Comparative effectiveness and patient-centered outcomes research: Enhancing uptake and use by patients, clinicians and payers
(Future Medicine, 2018-02-21)
Second-order correct versions of the usual KdV-BBM models for unidirectional propagation of long-crested, surface water waves are considered here. The focus will be on a class of recently derived mathematical models for ...
National trends in prescription drug expenditures and projections for 2018
(American Society of Health-System Pharmacists, 2018-05)
Purpose Historical trends and factors likely to influence future pharmaceutical expenditures are discussed, and projections are made for drug spending in 2018 in nonfederal hospitals, clinics, and overall (all sectors). Methods ...
Spending on Antineoplastic Agents in the United States, 2011-2016
(American Society of Clinical Oncology, 2018-09-18)
PURPOSE:: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system. There is little information on ...